Oramed Pharmaceuticals (ORMP) Leases (2022 - 2025)
Oramed Pharmaceuticals' Leases history spans 4 years, with the latest figure at $750000.0 for Q4 2025.
- For Q4 2025, Leases changed N/A year-over-year to $750000.0; the TTM value through Dec 2025 reached $750000.0, changed N/A, while the annual FY2025 figure was $750000.0, N/A changed from the prior year.
- Leases reached $750000.0 in Q4 2025 per ORMP's latest filing, down from $817000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $1.1 million in Q1 2022 to a low of $342000.0 in Q1 2025.
- Average Leases over 4 years is $789733.3, with a median of $817000.0 recorded in 2025.
- The largest YoY upside for Leases was 68.11% in 2025 against a maximum downside of 43.75% in 2025.
- A 4-year view of Leases shows it stood at $987000.0 in 2022, then decreased by 29.69% to $694000.0 in 2023, then dropped by 29.97% to $486000.0 in 2024, then surged by 54.32% to $750000.0 in 2025.
- Per Business Quant, the three most recent readings for ORMP's Leases are $750000.0 (Q4 2025), $817000.0 (Q3 2025), and $882000.0 (Q2 2025).